skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
04/04/2017
Application #:
14783713
Filing Dt:
10/09/2015
Publication #:
Pub Dt:
03/24/2016
Inventors:
Minoru Fujimoto, Tetsuji Naka, Satoshi Serada
Title:
PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR INFLAMMATORY DISEASE, AND METHOD FOR SCREENING PROPHYLACTIC AND/OR THERAPEUTIC DRUG FOR INFLAMMATORY DISEASE
Assignment: 1
Reel/Frame:
036767/0616Recorded: 10/09/2015Pages: 6
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
09/28/2015
Exec Dt:
09/28/2015
Exec Dt:
09/28/2015
Assignee:
7-6-8, SAITO-ASAGI
IBARAKI-SHI
OSAKA, JAPAN 5670085
Correspondent:
STEPHEN J. ROSENMAN, PH.D.
SEED IP LAW GROUP PLLC
701 FIFTH AVENUE, SUITE 5400
SEATTLE, WA 98104
Assignment: 2
Reel/Frame:
042697/0198Recorded: 06/13/2017Pages: 2
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
05/23/2017
Assignee:
5-1, AKEBONO-CHO 2-CHOME
KOCHI-SHI
KOCHI, JAPAN 780-8520
Correspondent:
STEPHEN J. ROSENMAN, PH.D.
SEED IP LAW GROUP LLP
701 FIFTH AVENUE, SUITE 5400
SEATTLE, WA 98104
Assignment: 3
Reel/Frame:
060424/0377Recorded: 07/01/2022Pages: 4
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
06/21/2022
Assignee:
1-1-1, IDAIDORI, YAHABA-CHO, SHIWA-GUN
IWATE, JAPAN 0283694
Correspondent:
QING LIN, PH.D.
SEED IP LAW GROUP LLP
701 5TH AVE, SUITE 5400
SEATTLE, WA 98104

Search Results as of: 05/02/2024 05:46 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT